The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
8 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,702,797 in first-year total cost, median $549,329.
Most frequent study sections
- Special Emphasis Panel[ZRG1 KUDS-P (50)]5
- Special Emphasis Panel[ZRG1 KUDS-F (50)]3
Most frequent institutions
- VIRGINIA COMMONWEALTH UNIVERSITY2
- DUKE UNIVERSITY1
- NORTHWESTERN UNIVERSITY AT CHICAGO1
- PURDUE UNIVERSITY1
- SOUTHERN RESEARCH INSTITUTE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Fenofibrate microemulsion for treating nitrogen mustard induced corneal injury1UG3EY036558-01A1 | MA, JIAN-XING JAYXU, QINGGUO | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $570,579 | ZRG1 |
| 2025 | Novel Anticonvulsants for Nerve Agents and Refractory Status Epilepticus1UG3NS138911-01A1 | REDDY, DOODIPALA SAMBA | TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR, TX | $539,000 | ZRG1 |
| 2024 | Platinum Based Countermeasures and Combinations with Protective Agents1UG3NS134957-01A1 | DAVISSON, VINCENT JO | PURDUE UNIVERSITY, IN | $590,302 | ZRG1 |
| 2024 | Identification and optimization of medical countermeasures for phosgene inhalation injuries1UG3ES035689-01A1 | ACHANTA, SATYANARAYANA | DUKE UNIVERSITY, NC | $555,283 | ZRG1 |
| 2024 | Synthetic Melanin for Accelerating Wound Repair1UG3AR084667-01 | GIANNESCHI, NATHAN CLAUDELU, KURT | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $536,233 | ZRG1 |
| 2023 | Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals1UG3AR083022-01 | ATHAR, MOHAMMADAUGELLI-SZAFRAN, CORINNE ELIZABETH | SOUTHERN RESEARCH INSTITUTE, AL | $835,063 | ZRG1 |
| 2023 | Identification and optimization of verapamil as a novel neuroprotective and anti-inflammatory agent for reducing long-term neurological morbidities following organophosphate-induced status epilepticus1UG3NS133630-01 | DESHPANDE, LAXMIKANT S | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $543,375 | ZRG1 |
| 2023 | Long-acting aldicarb hydrolase as a medical countermeasure for aldicarb poisoning1UG3NS134920-01 | ZHAN, CHANG-GUOZHENG, FANG | UNIVERSITY OF KENTUCKY, KY | $532,962 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.